NATALIE BURKS: Open Payments
NPI 1053304626 · PALESTINE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 22 payments from 9 companies in 2025. Trend: 2023 $1,389 · 2024 $841 · 2025 $517
Food & beverage: $472Education: $45
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $243 |
| Lilly USA, LLC | 4 | $103 |
| PFIZER INC. | 2 | $42 |
| Amgen Inc. | 2 | $30 |
| Novo Nordisk Inc | 1 | $25 |
| Seqirus USA Inc | 1 | $24 |
| Abbott Laboratories | 1 | $20 |
| ViiV Healthcare Company | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: JARDIANCE, ELIQUIS, Ozempic, Fluad, XIENCE SKYPOINT, MOUNJARO, ZEPBOUND, APRETUDE.
Industry payments across TX — which companies pay providers there.
